A medication to prevent migraines yielded positive results in a final experimental trial, the last step before having enough data to be submitted to the Food and Drug Administration for approval. Teva Pharmaceuticals announced Wednesday the successful completion of their Phase III HALO study of fremanezumab, a medication used to prevent migraines. “Migraine is a serious,…